COPD: Providing the right treatment for the right patient at the right time

By sjmartinez • January 8, 2023

Agusti A, Ambrosino N, Blackstock F, Bourbeau J, Casaburi R, Celli B, Crouch R, Negro RD, Dreher M, Garvey C, Gerardi D, Goldstein R, Hanania N, Holland AE, Kaur A, Lareau S, Lindenauer PK, Mannino D, Make B, Maltais F, Marciniuk JD, Meek P, Morgan M, Pepin JL, Reardon JZ, Rochester C, Singh S, Spruit MA, Steiner MC, Troosters T, Vitacca M, Clini E, Jardim J, Nici L, Raskin J, ZuWallack R. COPD: Providing the right treatment for the right patient at the right time. Respir Med. 2022 Dec 10;207:107041. doi: 10.1016/j.rmed.2022.107041. Epub ahead of print. PMID: 36610384.

Tags: Harbor UCLA, Publications, Pulmonary, Critical Care & Sleep Medicine

MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?

Senni M, Butler J, Cyr D, Anstrom KJ, Barash I, Bonaca MP, Budoff M, Cho MC, Crespo-Leiro MG, Corda S, Ezekowitz J, Lam CSP, Lewis[...]

Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee Arthroplasty: A Propensity-Matched Cohort Study

Wiener JM, Hamad CD, Chun RF, Mehany JD, Yeaman MR, Sheppard WL, Bernthal NM. Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee[...]

Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024

Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles[...]